ethyl (2E,4E)-5-(2,2-dimethylchromen-3-yl)-3-methylpenta-2,4-dienoate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: ethyl (2E,4E)-5-(2,2-dimethylchromen-3-yl)-3-methylpenta-2,4-dienoate
• 化学式: C₁₉H₂₂O₃
• 分子量: 298.4
• InChiKey: PBPPXVMWDKTPSA-CYZWUHAYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• USE OF PENTADIENOIC ACID DERIVATES FOR TREATEMENT OF HYPERURICEMIA
  申请人：Merck Patent GmbH

  公开号：EP1686983B1

  公开（公告）日：2007-07-11
• Use of pentadienoic acid derivatives for the treatment of hyperuricemia
  申请人：Boizel Robert

  公开号：US20070099854A1

  公开（公告）日：2007-05-03

  The use of a pentadienoic acid derivative of formula (I) for the preparation of a medicament for the prevention or treatment of hyperuricemia and/or one or several associated disorders or diseases, and/or for reducing the serum uric acid level of a subject. Medical compositions for these prevention and/or treatment, comprising such a pentadienoic acid derivative.
• USE OF PENTADIENOIC ACID DERIVATIVES FOR THE TREATMENT OF HYPERURICEMIA
  申请人：Boizel Robert

  公开号：US20100160410A1

  公开（公告）日：2010-06-24

  The use of a pentadienoic acid derivative of formula (I) for the preparation of a medicament for the prevention or treatment of hyperuricemia and/or one or several associated disorders or diseases, and/or for reducing the serum uric acid level of a subject. Medical compositions for these prevention and/or treatment, comprising such a pentadienoic acid derivative.